Posters

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30

Sunday, September 28

4:45 PM - 6:00 PM PT

2422 - Dynamic Change of Systemic Inflammatory Score in Predicting Survival of Patient with Unresectable Stage III Non-Small Cell Lung Cancer Treated by Definitive Chemoradiotherapy with or without Consolidate Immunotherapy: A Single-Arm, Retrospective Study
Speaker: Luo, Shihong, MD, MS - Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Beijing
4:45 PM - 6:00 PM PT

2423 - Rates of Fertility/Hormonal Preservation among Locally Advanced Cervical Cancer Patients Treated with Definitive Chemoradiation and Brachytherapy
Speaker: Lymberis, Stella, MD - New York University Langone Medical Center, New York, NY
4:45 PM - 6:00 PM PT

2424 - PIK3CD Affect Radiotherapy Resistance in LUAD Cells by Reprogramming Lipid Metabolism through PI3K/AKT Pathway
Speaker: Ma, Yingze, MB, MBBS - Shandong Cancer Hospital and Institute, Jinan, Shandong
4:45 PM - 6:00 PM PT

2425 - Single-Cell Atlas and Mechanistic Study of Lung Adenocarcinoma with Pulmonary Sarcomatoid Carcinoma
Speaker: Ma, Yuequn, PhD - Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong
4:45 PM - 6:00 PM PT

2426 - MGLL-Driven Ferroptosis via ATG9A-Mediated Lipid Mobilization Enhances Radiosensitivity in NSCLC
Speaker: Ma, Yujiao, MS - Shandong university, Jinan, Shandong
4:45 PM - 6:00 PM PT

2427 - Postoperative Radiotherapy in Surgically Resected Pathologic N2 Non-Small Cell Lung Cancer Post-Chemotherapy: A Multicenter Study
Speaker: Ma, Zeliang, MD - Mayo Clinic Rochester, Rochester, MN
4:45 PM - 6:00 PM PT

2428 - A Pilot Study to Evaluate Percussive Ventilation Breath Hold to Improve Lung Stereotactic Ablative Radiotherapy (PVB-SABR)
Speaker: Mai, Wilson, MD, PhD - Stanford University Cancer Center, Stanford, CA
4:45 PM - 6:00 PM PT

2429 - Durvalumab Concurrent and Following Thoracic Radiotherapy vs. Concurrent Chemoradiotherapy and Consolidation Durvalumab in Locally Advanced Non-Small Cell Lung Cancer: A Propensity Matched Analysis of a Prospective Trial
Speaker: Mankuzhy, Nikhil, MD - Memorial Sloan Kettering Cancer Center, Middletown Township, NJ
4:45 PM - 6:00 PM PT

2430 - Advancing Adaptive Radiotherapy with High-Fidelity CBCT-Based In-Situ Dose Calculation
Speaker: Hollingsworth, Scott, BS - Washington University in St. Louis School of Medicine, St Louis, MO
4:45 PM - 6:00 PM PT

2431 - Sociodemographic and Molecular Determinants of Disparities in NSCLC Outcomes: A Multi-Institutional Genomic Analysis
Speaker: Marquez, Cesar, MD, PhD - MD Anderson Cancer Center, Houston, TX
4:45 PM - 6:00 PM PT

2432 - Reirradiation for Pediatric Central Nervous System Tumors: Validation of an LQ Model-Based Approach for Critical Structure Dose Constraints and Clinical Outcomes
Speaker: Martynova, Natalia, MD - Dr. Berezin Medical Institute, Saint-Petersburg, Saint Pete
4:45 PM - 6:00 PM PT

2433 - Demographics, Disparities and Clinical Outcomes in Radiation Pneumonitis Hospitalizations with and without Lung Cancer: Retrospective Analysis of National Inpatient Sample (NIS)
Speaker: Mathew, Tijin, MD - Southeast Health, Dothan, Alabama